|
2025-01-23 |
2025-01-21 |
S
Sale
|
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Officer
|
4,000
-1.3%
9.00
USD 36,000
|
4,000
-1.3%
|
9.00
|
USD 36,000
|
|
|
2024-11-13 |
2024-11-11 |
S
Sale
|
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Officer
|
4,000
-1.2%
9.00
USD 36,000
|
4,000
-1.2%
|
9.00
|
USD 36,000
|
|
|
2024-08-09 |
2024-08-07 |
B
Purchase
|
Samaha Eli
Large shareholder
|
999,800
+11.7%
7.80
USD 7,798,440
|
999,800
+11.7%
|
7.80
|
USD 7,798,440
|
|
|
2024-07-12 |
2024-07-10 |
PS
Planned sale
|
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Officer
|
4,000
-1.2%
9.00
USD 36,000
|
4,000
-1.2%
|
9.00
|
USD 36,000
|
|
|
2024-05-03 |
2024-05-01 |
B
Purchase
|
Samaha Eli
Large shareholder
|
499,324
+6.2%
8.75
USD 4,369,085
|
499,324
+6.2%
|
8.75
|
USD 4,369,085
|
|
|
2024-05-03 |
2024-05-01 |
B
Purchase
|
Samaha Eli
Large shareholder
|
999,800
+14.3%
8.75
USD 8,748,250
|
999,800
+14.3%
|
8.75
|
USD 8,748,250
|
|
|
2024-02-22 |
2024-02-22 |
PS
Planned sale
|
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Officer
|
1,254
-0.4%
8.71
USD 10,922
|
1,254
-0.4%
|
8.71
|
USD 10,922
|
|
|
2023-11-22 |
2023-11-21 |
PS
Planned sale
|
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Officer
|
1,378
-0.4%
10.29
USD 14,180
|
1,378
-0.4%
|
10.29
|
USD 14,180
|
|
|
2023-11-16 |
2023-11-14 |
PS
Planned sale
|
GRAHAM RICHARD A
SVP, RESEARCH & DEVELOPMENT
Officer
|
2,482
-0.7%
10.22
USD 25,366
|
2,482
-0.7%
|
10.22
|
USD 25,366
|
|
|
2023-10-18 |
2023-10-16 |
PS
Planned sale
|
GRAHAM RICHARD A
SVP, RESEARCH & DEVELOPMENT
Officer
|
2,482
-0.7%
9.03
USD 22,412
|
2,482
-0.7%
|
9.03
|
USD 22,412
|
|
|
2023-09-18 |
2023-09-14 |
PS
Planned sale
|
GRAHAM RICHARD A
SVP, RESEARCH & DEVELOPMENT
Officer
|
2,482
-0.7%
9.89
USD 24,547
|
2,482
-0.7%
|
9.89
|
USD 24,547
|
|
|
2023-08-24 |
2023-08-22 |
PS
Planned sale
|
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Officer
|
1,807
-0.5%
9.47
USD 17,112
|
1,807
-0.5%
|
9.47
|
USD 17,112
|
|
|
2023-08-15 |
2023-08-11 |
PS
Planned sale
|
GRAHAM RICHARD A
SVP, RESEARCH & DEVELOPMENT
Officer
|
2,322
-0.7%
9.99
USD 23,197
|
2,322
-0.7%
|
9.99
|
USD 23,197
|
|
|
2023-07-18 |
2023-07-14 |
PS
Planned sale
|
GRAHAM RICHARD A
SVP, RESEARCH & DEVELOPMENT
Officer
|
2,322
-0.7%
9.84
USD 22,848
|
2,322
-0.7%
|
9.84
|
USD 22,848
|
|
|
2023-06-16 |
2023-06-14 |
PS
Planned sale
|
GRAHAM RICHARD A
SVP, RESEARCH & DEVELOPMENT
Officer
|
2,322
-0.7%
10.69
USD 24,822
|
2,322
-0.7%
|
10.69
|
USD 24,822
|
|
|
2023-06-12 |
2023-06-08 |
PS
Planned sale
|
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Officer
|
1,790
-0.5%
11.13
USD 19,923
|
1,790
-0.5%
|
11.13
|
USD 19,923
|
|
|
2023-05-17 |
2023-05-15 |
PS
Planned sale
|
GRAHAM RICHARD A
SVP, RESEARCH & DEVELOPMENT
Officer
|
2,322
-0.6%
11.26
USD 26,146
|
2,322
-0.6%
|
11.26
|
USD 26,146
|
|
|
2023-04-18 |
2023-04-14 |
PS
Planned sale
|
GRAHAM RICHARD A
SVP, RESEARCH & DEVELOPMENT
Officer
|
2,323
-0.6%
11.88
USD 27,597
|
2,323
-0.6%
|
11.88
|
USD 27,597
|
|
|
2023-03-16 |
2023-03-14 |
PS
Planned sale
|
GRAHAM RICHARD A
SVP, RESEARCH & DEVELOPMENT
Officer
|
2,323
-0.6%
10.32
USD 23,973
|
2,323
-0.6%
|
10.32
|
USD 23,973
|
|
|
2023-03-13 |
2023-03-09 |
S
Sale
|
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Officer
|
4,000
-1.1%
10.20
USD 40,800
|
4,000
-1.1%
|
10.20
|
USD 40,800
|
|
|
2023-03-08 |
2023-03-06 |
PS
Planned sale
|
GRAHAM RICHARD A
SVP, RESEARCH & DEVELOPMENT
Officer
|
2,323
-0.6%
10.05
USD 23,346
|
2,323
-0.6%
|
10.05
|
USD 23,346
|
|
|
2022-12-16 |
2022-12-14 |
S
Sale
|
Winningham Rick E
CHIEF EXECUTIVE OFFICER
Executive Director
|
50,000
-3.6%
11.19
USD 559,500
|
50,000
-3.6%
|
11.19
|
USD 559,500
|
|
|
2022-12-05 |
2022-12-01 |
S
Sale
|
GRAHAM RICHARD A
SVP, RESEARCH & DEVELOPMENT
Officer
|
2,084
-0.7%
10.73
USD 22,361
|
2,084
-0.7%
|
10.73
|
USD 22,361
|
|
|
2022-11-22 |
2022-11-18 |
S
Sale
|
Hindman Andrew A.
SVP, CHIEF FINANCIAL OFFICER
Officer
|
65,000
-13.7%
11.02
USD 716,242
|
65,000
-13.7%
|
11.02
|
USD 716,242
|
|
|
2022-08-18 |
2022-08-16 |
S
Sale
|
GRAHAM RICHARD A
SVP, DEVELOPMENT
Officer
|
4,906
-1.3%
9.71
USD 47,640
|
4,906
-1.3%
|
9.71
|
USD 47,640
|
|
|
2022-08-11 |
2022-08-09 |
S
Sale
|
GRAHAM RICHARD A
SVP, DEVELOPMENT
Officer
|
15,086
-3.9%
8.79
USD 132,606
|
15,086
-3.9%
|
8.79
|
USD 132,606
|
|
|
2022-05-24 |
2022-05-23 |
PS
Planned sale
|
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Officer
|
1,081
-0.3%
8.93
USD 9,653
|
1,081
-0.3%
|
8.93
|
USD 9,653
|
|
|
2022-03-02 |
2022-02-28 |
PS
Planned sale
|
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Officer
|
2,356
-0.7%
10.16
USD 23,947
|
2,356
-0.7%
|
10.16
|
USD 23,947
|
|
|
2021-03-11 |
2021-03-09 |
S
Sale
|
WORBOYS PHILIP D
SVP, Research & Transl Science
Officer
|
8,829
-2.5%
20.00
USD 176,580
|
8,829
-2.5%
|
20.00
|
USD 176,580
|
|
|
2020-12-16 |
2020-12-14 |
S
Sale
|
GRAHAM RICHARD A
SVP, Development
Officer
|
7,500
-5.7%
19.47
USD 146,058
|
7,500
-5.7%
|
19.47
|
USD 146,058
|
|
|
2020-12-07 |
2020-12-03 |
S
Sale
|
WORBOYS PHILIP D
SVP, Research & Transl Science
Officer
|
4,246
-1.3%
18.00
USD 76,428
|
4,246
-1.3%
|
18.00
|
USD 76,428
|
|
|
2020-08-24 |
2020-08-21 |
S
Sale
|
HAUMANN BRETT K
Chief Medical Officer
Officer
|
25,000
-8.1%
18.29
USD 457,240
|
25,000
-8.1%
|
18.29
|
USD 457,240
|
|
|
2020-08-24 |
2020-08-20 |
S
Sale
|
WORBOYS PHILIP D
SVP, Research & Transl Science
Officer
|
17,103
-4.9%
18.00
USD 307,854
|
17,103
-4.9%
|
18.00
|
USD 307,854
|
|
|
2019-12-16 |
2019-12-12 |
S
Sale
|
SABESAN VIJAY
SVP, Technical Operations
Officer
|
1,027
-0.7%
21.03
USD 21,598
|
1,027
-0.7%
|
21.03
|
USD 21,598
|
|
|
2019-05-20 |
2019-05-17 |
S
Sale
|
O'Connor Donal
|
2,673
-8.8%
20.19
USD 53,968
|
2,673
-8.8%
|
20.19
|
USD 53,968
|
|
|
2019-05-20 |
2019-05-16 |
S
Sale
|
O'Connor Donal
|
1,327
-4.2%
21.00
USD 27,867
|
1,327
-4.2%
|
21.00
|
USD 27,867
|
|
|
2019-03-06 |
2019-03-05 |
S
Sale
|
HEGDE SHARATHCHANDRA S
SVP, Research
|
5,690
-2.1%
24.50
USD 139,405
|
5,690
-2.1%
|
24.50
|
USD 139,405
|
|
|
2019-03-06 |
2019-03-04 |
S
Sale
|
HEGDE SHARATHCHANDRA S
SVP, Research
|
3,343
-1.2%
25.06
USD 83,764
|
3,343
-1.2%
|
25.06
|
USD 83,764
|
|
|
2018-09-14 |
2018-09-12 |
S
Sale
|
WORBOYS PHILIP D
SVP, Translational Science
Officer
|
6,393
-3.7%
28.50
USD 182,201
|
6,393
-3.7%
|
28.50
|
USD 182,201
|
|
|
2018-08-29 |
2018-08-27 |
S
Sale
|
Shafer Bradford J
EVP, Gen. Counsel, Secretary
Officer
|
7,119
-7.8%
27.71
USD 197,282
|
7,119
-7.8%
|
27.71
|
USD 197,282
|
|
|
2018-08-16 |
2018-08-15 |
S
Sale
|
GALA RENEE D
SVP, Chief Financial Officer
Officer
|
1,700
-1.0%
27.43
USD 46,623
|
1,700
-1.0%
|
27.43
|
USD 46,623
|
|
|
2018-08-16 |
2018-08-15 |
S
Sale
|
GALA RENEE D
SVP, Chief Financial Officer
Officer
|
39,839
-18.7%
26.71
USD 1,064,032
|
39,839
-18.7%
|
26.71
|
USD 1,064,032
|
|
|
2018-08-16 |
2018-08-14 |
S
Sale
|
GALA RENEE D
SVP, Chief Financial Officer
Officer
|
2,204
-1.0%
27.74
USD 61,136
|
2,204
-1.0%
|
27.74
|
USD 61,136
|
|
|
2018-08-09 |
2018-08-08 |
S
Sale
|
Shafer Bradford J
EVP, Gen. Counsel, Secretary
Officer
|
25,355
-20.5%
27.85
USD 706,182
|
25,355
-20.5%
|
27.85
|
USD 706,182
|
|
|
2018-08-09 |
2018-08-07 |
S
Sale
|
Shafer Bradford J
EVP, Gen. Counsel, Secretary
Officer
|
4,127
-3.2%
28.03
USD 115,686
|
4,127
-3.2%
|
28.03
|
USD 115,686
|
|
|
2018-08-09 |
2018-08-07 |
S
Sale
|
Shafer Bradford J
EVP, Gen. Counsel, Secretary
Officer
|
1,818
-1.4%
28.99
USD 52,707
|
1,818
-1.4%
|
28.99
|
USD 52,707
|
|
|
2018-06-08 |
2018-06-08 |
S
Sale
|
Shafer Bradford J
EVP, Gen. Counsel, Secretary
|
3,900
-2.9%
23.66
USD 92,260
|
3,900
-2.9%
|
23.66
|
USD 92,260
|
|
|
2018-06-08 |
2018-06-06 |
S
Sale
|
Shafer Bradford J
EVP, Gen. Counsel, Secretary
|
10,140
-7.1%
24.09
USD 244,268
|
10,140
-7.1%
|
24.09
|
USD 244,268
|
|
|
2018-05-23 |
2018-05-21 |
B
Purchase
|
MALKIEL BURTON G
Non-Executive Director
|
1,000
+1.8%
22.54
USD 22,540
|
1,000
+1.8%
|
22.54
|
USD 22,540
|
|
|
2018-05-22 |
2018-05-18 |
S
Sale
|
GALA RENEE D
SVP, Chief Financial Officer
Officer
|
10,000
-4.1%
24.29
USD 242,877
|
10,000
-4.1%
|
24.29
|
USD 242,877
|
|
|
2017-09-08 |
2017-09-06 |
S
Sale
|
Shafer Bradford J
EVP, Gen. Counsel, Secretary
|
14,670
-9.8%
30.77
USD 451,350
|
14,670
-9.8%
|
30.77
|
USD 451,350
|
|
|
2017-08-23 |
2017-08-21 |
B
Purchase
|
PASQUALONE FRANK
SVP, Chief Comm Ops Officer
|
4,000
+1.9%
26.34
USD 105,359
|
4,000
+1.9%
|
26.34
|
USD 105,359
|
|
|
2017-08-14 |
2017-08-11 |
B
Purchase
|
MALKIEL BURTON G
|
15,000
+inf%
24.59
USD 368,816
|
15,000
+inf%
|
24.59
|
USD 368,816
|
|
|
2017-08-14 |
2017-08-11 |
B
Purchase
|
MALKIEL BURTON G
|
15,000
+46.1%
24.59
USD 368,855
|
15,000
+46.1%
|
24.59
|
USD 368,855
|
|
|
2017-08-14 |
2017-08-11 |
B
Purchase
|
WHITESIDES GEORGE M
|
4,000
+inf%
24.69
USD 98,764
|
4,000
+inf%
|
24.69
|
USD 98,764
|
|
|
2017-08-11 |
2017-08-11 |
B
Purchase
|
Fore Henrietta
|
6,000
+33.3%
23.99
USD 143,932
|
6,000
+33.3%
|
23.99
|
USD 143,932
|
|
|
2017-08-11 |
2017-08-11 |
B
Purchase
|
Winningham Rick E
Chief Executive Officer
Executive Director
|
10,000
+1.2%
24.50
USD 245,000
|
10,000
+1.2%
|
24.50
|
USD 245,000
|
|
|
2017-03-08 |
2017-03-07 |
S
Sale
|
HAUMANN BRETT K
SVP Clin Dev & Chief Med Ofc
|
424
-0.3%
30.80
USD 13,059
|
424
-0.3%
|
30.80
|
USD 13,059
|
|
|
2017-03-08 |
2017-03-06 |
S
Sale
|
HAUMANN BRETT K
SVP Clin Dev & Chief Med Ofc
|
13,576
-7.6%
31.52
USD 427,916
|
13,576
-7.6%
|
31.52
|
USD 427,916
|
|
|
2017-03-07 |
2017-03-03 |
S
Sale
|
Shafer Bradford J
EVP, Gen. Counsel, Secretary
|
26,829
-14.2%
31.86
USD 854,772
|
26,829
-14.2%
|
31.86
|
USD 854,772
|
|
|
2016-08-25 |
2016-08-25 |
S
Sale
|
HAUMANN BRETT K
SVP Clin Dev & Chief Med Ofc
Officer
|
4,491
-2.3%
27.99
USD 125,703
|
4,491
-2.3%
|
27.99
|
USD 125,703
|
|
|
2016-08-22 |
2016-08-22 |
S
Sale
|
Shafer Bradford J
EVP, Gen. Counsel, Secretary
Officer
|
37,078
-15.9%
27.16
USD 1,007,038
|
37,078
-15.9%
|
27.16
|
USD 1,007,038
|
|
|
2016-08-23 |
2016-08-19 |
S
Sale
|
HAUMANN BRETT K
SVP Clin Dev & Chief Med Ofc
Officer
|
9,509
-4.6%
27.97
USD 265,967
|
9,509
-4.6%
|
27.97
|
USD 265,967
|
|
|
2016-08-22 |
2016-08-19 |
S
Sale
|
Shafer Bradford J
EVP, Gen. Counsel, Secretary
Officer
|
4,870
-2.0%
28.14
USD 137,042
|
4,870
-2.0%
|
28.14
|
USD 137,042
|
|
|
2016-08-22 |
2016-08-18 |
S
Sale
|
Shafer Bradford J
EVP, Gen. Counsel, Secretary
Officer
|
7,174
-2.9%
28.55
USD 204,818
|
7,174
-2.9%
|
28.55
|
USD 204,818
|
|
|
2016-03-15 |
2016-03-14 |
B
Purchase
|
GLAXOSMITHKLINE PLC
Large shareholder
|
1,301,015
+15.6%
23,027,965.50
USD 29,959,728,534,983
|
1,301,015
+15.6%
|
23,027,965.50
|
USD 29,959,728,534,983
|
|
|
2015-08-18 |
2015-08-18 |
B
Purchase
|
LEE JUNNING
Sr. VP, Technical Operations
Officer
|
9,000
+inf%
12.90
USD 116,100
|
9,000
+inf%
|
12.90
|
USD 116,100
|
|
|
2015-08-18 |
2015-08-18 |
B
Purchase
|
MALKIEL BURTON G
Non-Executive Director
|
10,000
+94.6%
12.92
USD 129,200
|
10,000
+94.6%
|
12.92
|
USD 129,200
|
|
|
2015-08-17 |
2015-08-17 |
B
Purchase
|
GALA RENEE D
SVP, Chief Financial Officer
Officer
|
5,000
+3.2%
12.16
USD 60,800
|
5,000
+3.2%
|
12.16
|
USD 60,800
|
|
|
2015-08-17 |
2015-08-17 |
B
Purchase
|
Winningham Rick E
Chief Executive Officer
Executive Director
|
16,860
+2.9%
12.13
USD 204,512
|
16,860
+2.9%
|
12.13
|
USD 204,512
|
|
|
2015-08-17 |
2015-08-14 |
B
Purchase
|
Winningham Rick E
Chief Executive Officer
Executive Director
|
63,140
+12.1%
11.79
USD 744,421
|
63,140
+12.1%
|
11.79
|
USD 744,421
|
|
|
2015-08-17 |
2015-08-13 |
B
Purchase
|
GALA RENEE D
SVP, Chief Financial Officer
Officer
|
5,000
+3.3%
12.19
USD 60,950
|
5,000
+3.3%
|
12.19
|
USD 60,950
|
|
